A single, subcutaneous injection of 1.14 mL/100 lb. (2.5 mg/kg) of bodyweight delivers a full course of therapy, thereby minimizing labor and handling stress.
DRAXXIN Injectable Solution is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass; triamilide. Each mL of DRAXXIN contains 100 mg of tulathromycin as the free base in a 50% propylene glycol vehicle, monothioglycerol (5 mg/mL), with citric and hydrochloric acids added to adjust pH.
A single, subcutaneous injection of 1.14 mL/100 lb. (2.5 mg/kg) of bodyweight delivers a full course of therapy, thereby minimizing labor and handling stress.
DRAXXIN Injectable Solution is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass; triamilide. Each mL of DRAXXIN contains 100 mg of tulathromycin as the free base in a 50% propylene glycol vehicle, monothioglycerol (5 mg/mL), with citric and hydrochloric acids added to adjust pH.
A single, subcutaneous injection of 1.14 mL/100 lb. (2.5 mg/kg) of bodyweight delivers a full course of therapy, thereby minimizing labor and handling stress.
DRAXXIN Injectable Solution is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass; triamilide. Each mL of DRAXXIN contains 100 mg of tulathromycin as the free base in a 50% propylene glycol vehicle, monothioglycerol (5 mg/mL), with citric and hydrochloric acids added to adjust pH.
Spectramast LC is indicated for the treatment of clinical mastitis in lactating dairy cattle associated with coagulase-negative staphylococci, Streptococcus dysgalactiae, and Escherichia coli.
Dosage: Each 10 ml tube of Spectramast LC contains the equivalent to 125 mg ceftiofur in a cottonseed oil base. Infuse one tube into each affected quarter.
For use in chickens up to 7 days of age as an aid in the control of airsacculitis caused by either Mycoplasma Synoviae or Mycoplasma gallisepticum susceptible to lincomycin-spectinomycin.
Complicated Chronic Respiratory disease (Air Sac Infection) caused by Escherichia Coli and M. Gallisepticum susceptible to lincomycin-spectinomycin.
One-day antibiotic mastitis treatment for lactating dairy cows in ready-to-use, disposable syringes. For effective intramammary infusion into the lactating cow. Provides bactericidal activity against both gram-positive and gram-negative bacteria, especially penicillin-resistant Streptococcus agalactiae and Staphylococcus aureus.
For the treatment of disease in dairy cattle, beef cattle and swine. Ready-to-use solution of the broad-spectrum antibiotic oxytetracycline by injection. Delivers rapid sustainable blood levels.
Indicated for the treatment of the following diseases in dairy cattle and beef cattle when due to oxytetracycline-susceptible organisms: pneumonia, shipping fever complex, pinkeye, footrot, diphtheria, lepto, wound infections and acute metritis.
In beef and non-lactating dairy cattle, Macrosyn is approved for the control & treatment of bovine respiratory disease (BRD) (Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, Mycoplasma bovis), treatment of bovine foot rot (Fusobacterium necrophorum, Porphyromonas levii), and treatment of pink eye (Moraxella bovis)
In calves (suckling, dairy and veal calves) Macrosyn is approved for the treatment of bovine respiratory disease (BRD) (M. haemolytica, P. multocida, H. somni, M. bovis)
In beef and non-lactating dairy cattle, Macrosyn is approved for the control & treatment of bovine respiratory disease (BRD) (Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, Mycoplasma bovis), treatment of bovine foot rot (Fusobacterium necrophorum, Porphyromonas levii), and treatment of pink eye (Moraxella bovis)
In calves (suckling, dairy and veal calves) Macrosyn is approved for the treatment of bovine respiratory disease (BRD) (M. haemolytica, P. multocida, H. somni, M. bovis)
In beef and non-lactating dairy cattle, Macrosyn is approved for the control & treatment of bovine respiratory disease (BRD) (Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, Mycoplasma bovis), treatment of bovine foot rot (Fusobacterium necrophorum, Porphyromonas levii), and treatment of pink eye (Moraxella bovis)
In calves (suckling, dairy and veal calves) Macrosyn is approved for the treatment of bovine respiratory disease (BRD) (M. haemolytica, P. multocida, H. somni, M. bovis)
Indicated for the treatment of bovine respiratory disease (pneumonia) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in beef and dairy cattle.
Do not use in calves to be processed for veal. Do not use in female dairy cattle 20 months of age or older.
Sustain III Boluses are intended for oral administration to beef cattle and non-lactating dairy cattle. Sustain III Boluses are indicated for the treatment of the following diseases when caused by one or more of the following pathogenic organisms sensitive to sulfamethazine: Bacterial Pneumonia and Bovine Respiratory Disease Complex, (Shipping Fever Complex) (Pasteurella spp.), Colibacillosis (Bacterial Scours) (E.coli), Necrotic pododermatitis (Foot Rot), Calf Diphtheria (Fusobacterium necrophorum), and Acute Metritis (Streptococcus spp.)
Indicated for the treatment of bovine respiratory disease (BRD) in beef and non-lactating dairy cattle and for treatment and control of swine respiratory disease (SRD) in swine.
Each ml of Baytril 100 injectable solution contains 100 mb enrofloxacin.
Indicated for the treatment of bovine respiratory disease (BRD) in beef and non-lactating dairy cattle and for treatment and control of swine respiratory disease (SRD) in swine.
Each ml of Baytril 100 injectable solution contains 100 mb enrofloxacin.
Indicated for the treatment of bovine respiratory disease (BRD) in beef and non-lactating dairy cattle and for treatment and control of swine respiratory disease (SRD) in swine.
Each ml of Baytril 100 injectable solution contains 100 mb enrofloxacin.
An antihistamine injectable solution for cattle and horses. This rapid acting antihistamine contains the active ingredient, tripelennamine hydrochloride to block harmful histamine effects which can delay recovery time. Labeled for beef and dairy cattle calves (2 months of age and older) and horses.
Flunixin is a synthetic drug more commonly made into flunixin meglamine, which is the primary component of Banamine, commonly used for pain, inflammation and pyrexia associated with colic, musculoskeletal disorders and various respiratory conditions in horses.
Increxxa contains tulathromycin, the same macrolide antibiotic veterinarians and the cattle industry have depended on to control and treat bovine respiratory disease (BRD) in cattle for more than 15 years. It's a go-to antibiotic for beef and dairy producers because of its one-time use, extended duration of action, ease of administration and broad-spectrum control
Increxxa contains tulathromycin, the same macrolide antibiotic veterinarians and the cattle industry have depended on to control and treat bovine respiratory disease (BRD) in cattle for more than 15 years. It's a go-to antibiotic for beef and dairy producers because of its one-time use, extended duration of action, ease of administration and broad-spectrum control
Vitamin K1 Injection is indicated in coagulation disorders when caused by vitamin K deficiency or interference with vitamin K activity; to counter hypoprothrombinemia induced by ingestion of anticoagulant rodenticides; or to counter hypoprothrombinemia caused by consumption of bishydroxycoumarin found in spoiled and moldy sweet clover
Vitamin K1 Injection contains 10 mg phytonadione per ml. The dosage range for cattle, calves, horses, swine, sheep and goats is 0.5 - 2.5 mg/kg SQ or IM. The dosage range for dogs and cats is 0.25 - 5mg/kg SQ or IM
For use as an aid in the treatment of hypocalcemia (parturient paresis, milk fever), hypomagnesemia (grass tetany), and other conditions associated with calcium, magnesium, phosphorus, and potassium deficiencies in cattle.
Micotil is indicated for the control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica.
For the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni and for the treatment of bovine respiratory disease (ORD) associated with Mannheimia haemolytica.
The recommended dosage is 1 ml per 100 lbs body weight for calves up to 1 year of age; 1 ml per 150 lbs for cattle 1-2 years of age; and 1 ml per 200 lbs for cattle over 2 years of age.
Multimin 90 should be administered to cattle by SQ or IM injection.
LongRange contains eprinomectin , an extended release injectable parasiticide for cattle on pastures useful for the treatment and control of roundworms, lungworms, grubs, and mites.
Each ml of LongRange contains 50 mg eprinomectin, a macrocyclic lactone.
LongRange contains eprinomectin , an extended release injectable parasiticide for cattle on pastures useful for the treatment and control of roundworms, lungworms, grubs, and mites.
Each ml of LongRange contains 50 mg eprinomectin, a macrocyclic lactone.
LongRange contains eprinomectin , an extended release injectable parasiticide for cattle on pastures useful for the treatment and control of roundworms, lungworms, grubs, and mites.
Each ml of LongRange contains 50 mg eprinomectin, a macrocyclic lactone.
An FDA-approved sterile, ready-to-use injectable antimicrobial solution that contains enrofloxacin, a broad-spectrum fluoroquinolone antimicrobial agent.
Approved for Single Dose & Multi-Day Treatment and Control
An FDA-approved sterile, ready-to-use injectable antimicrobial solution that contains enrofloxacin, a broad-spectrum fluoroquinolone antimicrobial agent.
Approved for Single Dose & Multi-Day Treatment and Control
An FDA-approved sterile, ready-to-use injectable antimicrobial solution that contains enrofloxacin, a broad-spectrum fluoroquinolone antimicrobial agent.
Approved for Single Dose & Multi-Day Treatment and Control